MA’s ZEPHYR Phase 2 trial in schizophrenia Last patient visit completed for ML-004’s IRIS Phase 2 trial in autism spectrum disorderTopline results from both Phase 2 trials expected by mid-August 2026 ...
Abstract: This paper investigates Binary-Phase Shift Keying (BPSK) based Time-Domain Single Carrier Index Modulation (TDSC-IM) optical signaling for next generation very high speed Passive Optical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results